12/05/2025 – AB Science reports its revenues for the year 2024 and provides an update on its activities Download PDF Post navigationPreviousPrevious post:AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual MeetingNextNext post:CNews – Interview of Alain MoussyRelated PostsAB Science announces the settlement delivery of its latest capital increase for €1.8 millionMay 23, 2025AB Science announces the successful completion of a EUR 1.8 million private placementMay 20, 2025AB Science receives Chinese patent protecting masitinib in the treatment of Covid-19 until 2041May 19, 2025AB Science reports a new publication in the scientific journal PLOS OneMay 15, 2025CNews – Interview of Alain MoussyMay 12, 2025AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual MeetingMay 5, 2025
AB Science announces the settlement delivery of its latest capital increase for €1.8 millionMay 23, 2025
AB Science receives Chinese patent protecting masitinib in the treatment of Covid-19 until 2041May 19, 2025
AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual MeetingMay 5, 2025
